We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

Another advantage floor trusses bring to the table is their flatness. Each one is a clone of the other. Normal dimensional ...

Like a musical composition, there is a particular category of buildings whose history might be compared to an unfinished symphony. Alternating between high notes and moments of silence, these ...

Liz Truss, the shortest-serving prime minister in British history, lost her seat to a candidate representing the Labour Party, which has swept to power in the country's general election ...

Merck (NYSE:MRK) announced Saturday that its anti-PD-1 therapy Keytruda (pembrolizumab) as part of a combination regimen reduced the risk of death by 20% as a first-line option for certain ...

Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer The FDA has approved Merck's Keytruda (pembrolizumab) in combination with pemetrexed and platinum chemotherapy for first ...

At 06:48 BST on Friday 5 July, former Prime Minister Liz Truss lost her South West Norfolk seat by just 630 votes, overturning her majority of more than 26,000. She had arrived at the count just ...

Liz Truss has endorsed Donald Trump to win this year's US presidential election, saying the "world was safer" when he was in the White House. The former prime minister said the world was "on the ...

Paving The Way For The World’s First Treatment For Cancer Cachexia The mid-stage trial results showed that patients that The FDA approves MRK's Keytruda for first-line treatment of malignant ...

MRK and Daiichi Sankyo's patritumab deruxtecan shows statistically significant progression-free survival improvement in previously treated EGFR-mutated NSCLC. Wednesday, the FDA approved Merck ...